Clinical Trials Sponsored by Laboratorio Elea Phoenix S.A.

Total 22 results

Laboratorio Elea Phoenix S.A.

Completed

Bioequivalence Study of Two Formulatiosns With the Asscociaton of Efavirenz, Emtricitabine and Tenofovir

Healthy

Argentina
Laboratorio Elea Phoenix S.A.

Completed

Perioperative Use of Desmopressin (DDAVP) in Breast Cancer

Breast Cancer

Argentina
Laboratorio Elea Phoenix S.A.

Completed

Safety and Clinical Effectiveness of Intravitreal Bevacizumab (Lumiere®) in Patients With Wet Age-related Macular Degeneration (Wet AMD)

Age-Related Macular Degeneration

Argentina
Laboratorio Elea Phoenix S.A.

Completed

Desmopressin (DDAVP) in Patients With Colorectal Cancer and Rectal Bleeding

Colorectal Cancer | Rectal Bleeding

Argentina
Laboratorio Elea Phoenix S.A.

Completed

Concurrent Treatment of Squamous Cell Carcinoma or Adenocarcinoma of the Cervix With CIGB-300 for Local Application

Squamous Cell Carcinoma of the Cervix | Adenocarcinoma of the Cervix

Argentina
Laboratorio Elea Phoenix S.A.

Completed

Bioequivalence Study of Two Formulations With the Association of Tenofovir 300 mg and Emtricitabine 200 mg.

Acquired Immunodeficiency Syndrome

Argentina
Laboratorio Elea Phoenix S.A.

Completed

Immunotherapy With Racotumomab Versus Support Treatment in Advanced Non-small Cell Lung Cancer Patients

Advanced Non-small Cell Lung Cancer

Argentina
Laboratorio Elea Phoenix S.A.

Completed

Racotumomab in Patients With High-risk Neuroblastoma

Neuroblastoma

Argentina
Laboratorio Elea Phoenix S.A.

Terminated

Recurrent and Nonrecurrent Condyloma Treatment

Recurrent Condyloma | Nonrecurrent Condyloma

Argentina
Laboratorio Elea Phoenix S.A.
Syneos Health

Recruiting

Double-blind Study to Evaluate the PK, Efficacy, Safety and Immunogenicity of MB12 Versus Keytruda® in Stage IV NSCLC

Non Small Cell Lung Cancer Metastatic

Argentina
Laboratorio Elea Phoenix S.A.
DominguezLab S.R.L.

Completed

Bioequivalence Study of Two Extended Release Formulations Containing 50 mg of Quetiapine.

Healthy

Argentina
mAbxience Research S.L.
Laboratorio Elea Phoenix S.A.; Libbs Farmacêutica LTDA

Completed

Bioequivalence Study Bevacizumab Biosimilar (BEVZ92) Versus Bevacizumab (AVASTIN®) in First-line Treatment mCRC Patients

Metastatic Colorectal Cancer (mCRC)

Argentina, Brazil, India, Spain, Ukraine
Laboratorio Elea Phoenix S.A.
Drugs for Neglected Diseases

Recruiting

Shorter Benznidazole Regimens Compared to the Standard Regimen for Chagas Disease (NuestroBen)

Chagas Disease

Argentina
Center for Clinical Pharmacology Research Bdbeq...
Laboratorio Elea Phoenix S.A.

Unknown

Single Dose Two-periods Crossover Bioequivalence Study of Darifenacin Tablets in Healthy Volunteers.

Bioequivalency

Uruguay
Center for Clinical Pharmacology Research Bdbeq...
Laboratorio Elea Phoenix S.A.

Unknown

Single Dose Bioequivalence Study of Darifenacin Tablets 7.5 mg in Fed Healthy Volunteers.

Bioequivalency

Uruguay
Recombio SL
Eurofarma Laboratorios S.A.; Laboratorio Elea Phoenix S.A.; Innogene Kalbiotech... and other collaborators

Unknown

Immunotherapy With Racotumomab in Advanced Lung Cancer

NSCLC | Lung Cancer, Non-small Cell

Brazil, Indonesia, Argentina, Cuba, Philippines, Singapore, Thailand
Laboratorio Elea Phoenix S.A.
Ministerio de Ciencia e Innovación, Spain

Completed

Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides

Glioma | Neuroblastoma | Retinoblastoma | Wilm's Tumor | Ewing's Sarcoma

Argentina
Laboratorio Elea Phoenix S.A.
Carlos R. Rojo, MD; Facultad de Medicina, Universidad de Buenos Aires, UBA

Completed

Telmisartan for Treatment of COVID-19 Patients

COVID-19 Drug Treatment

Argentina
mAbxience Research S.L.
Laboratorio Elea Phoenix S.A.; Libbs Farmacêutica LTDA; Innogene Kalbiotech Pte... and other collaborators

Completed

Study of RTXM83 Plus CHOP Chemotherapy Versus a Rituximab Plus CHOP Therapy in Patients With Non Hodgkin's Lymphoma

Diffuse Large B-cell Lymphoma

Malaysia, Argentina, Colombia, India, South Africa, Philippines, Brazil, Russian Federation, Indonesia, Iran, Islamic Republic of, Mexico, Paraguay
Laboratorio Elea Phoenix S.A.
China National Biotec Group Company Limited; Beijing Institute of Biological... and other collaborators

Completed

Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19)

COVID-19 Virus Infection

Argentina
Inmunova S.A.
Hospital Italiano de Buenos Aires; Laboratorio Elea Phoenix S.A.; Hospital de... and other collaborators

Completed

Effectiveness and Safety Study of Specific Hyperimmune Equine Serum for the Treatment of Severe Hospitalized SARS-CoV-2 in Adults: Retrospective Cohort Study

Covid19

Argentina
Laboratorio Elea Phoenix S.A.
Universidad Nacional de Salta; Centro de Investigación Veterinaria Tandil CIVETAN and other collaborators

Completed

Ivermectin Effect on SARS-CoV-2 Replication in Patients With COVID-19

COVID-19 Drug Treatment

Argentina

Clinical Trials Sponsored by Laboratorio Elea Phoenix S.A.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Japan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations